A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization

The vast majority of severe (Type 0) spinal muscular atrophy (SMA) cases are caused by homozygous deletions of survival motor neuron 1 (SMN1). We report a case in which the patient has two copies of SMN1 but clinically presents as Type 0 SMA. The patient is an African American male carrying a homozy...

Full description

Bibliographic Details
Main Authors: Leping Li, Lalith Perera, Sonia A. Varghese, Yael Shiloh-Malawsky, Senyene E. Hunter, Tam P. Sneddon, Cynthia M. Powell, A. Gregory Matera, Zheng Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2023.1259380/full
_version_ 1827318417297768448
author Leping Li
Lalith Perera
Sonia A. Varghese
Yael Shiloh-Malawsky
Senyene E. Hunter
Tam P. Sneddon
Cynthia M. Powell
A. Gregory Matera
Zheng Fan
author_facet Leping Li
Lalith Perera
Sonia A. Varghese
Yael Shiloh-Malawsky
Senyene E. Hunter
Tam P. Sneddon
Cynthia M. Powell
A. Gregory Matera
Zheng Fan
author_sort Leping Li
collection DOAJ
description The vast majority of severe (Type 0) spinal muscular atrophy (SMA) cases are caused by homozygous deletions of survival motor neuron 1 (SMN1). We report a case in which the patient has two copies of SMN1 but clinically presents as Type 0 SMA. The patient is an African American male carrying a homozygous maternally inherited missense variant (c.796T>C) in a cis-oriented SMN1 duplication on one chromosome and an SMN1 deletion on the other chromosome (genotype: 2*+0). Initial extensive genetic workups including exome sequencing were negative. Deletion analysis used in the initial testing for SMA also failed to detect SMA as the patient has two copies of SMN1. Because of high clinical suspicion, SMA diagnosis was finally confirmed based on full-length SMN1 sequencing. The patient was initially treated with risdiplam and later gene therapy with onasemnogene abeparvovec at 5 months without complications. The patient’s muscular weakness has stabilized with mild improvement. The patient is now 28 months old and remains stable and diffusely weak, with stable respiratory ventilatory support. This case highlights challenges in the diagnosis of SMA with a non-deletion genotype and provides a clinical example demonstrating that disruption of functional SMN protein polymerization through an amino acid change in the YG-box domain represents a little known but important pathogenic mechanism for SMA. Clinicians need to be mindful about the limitations of the current diagnostic approach for SMA in detecting non-deletion genotypes.
first_indexed 2024-03-11T21:31:09Z
format Article
id doaj.art-bd5ba1db86b34213987350d7bbf7dbd1
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-24T23:58:38Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-bd5ba1db86b34213987350d7bbf7dbd12024-03-14T10:51:11ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022023-09-011710.3389/fncel.2023.12593801259380A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterizationLeping Li0Lalith Perera1Sonia A. Varghese2Yael Shiloh-Malawsky3Senyene E. Hunter4Tam P. Sneddon5Cynthia M. Powell6A. Gregory Matera7Zheng Fan8Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Durham, NC, United StatesGenome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Durham, NC, United StatesDivision of Pediatric Neurology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDivision of Pediatric Neurology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDivision of Pediatric Neurology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Pathology and Lab Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDivision of Genetics and Metabolism, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesIntegrative Program for Biological and Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDivision of Pediatric Neurology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesThe vast majority of severe (Type 0) spinal muscular atrophy (SMA) cases are caused by homozygous deletions of survival motor neuron 1 (SMN1). We report a case in which the patient has two copies of SMN1 but clinically presents as Type 0 SMA. The patient is an African American male carrying a homozygous maternally inherited missense variant (c.796T>C) in a cis-oriented SMN1 duplication on one chromosome and an SMN1 deletion on the other chromosome (genotype: 2*+0). Initial extensive genetic workups including exome sequencing were negative. Deletion analysis used in the initial testing for SMA also failed to detect SMA as the patient has two copies of SMN1. Because of high clinical suspicion, SMA diagnosis was finally confirmed based on full-length SMN1 sequencing. The patient was initially treated with risdiplam and later gene therapy with onasemnogene abeparvovec at 5 months without complications. The patient’s muscular weakness has stabilized with mild improvement. The patient is now 28 months old and remains stable and diffusely weak, with stable respiratory ventilatory support. This case highlights challenges in the diagnosis of SMA with a non-deletion genotype and provides a clinical example demonstrating that disruption of functional SMN protein polymerization through an amino acid change in the YG-box domain represents a little known but important pathogenic mechanism for SMA. Clinicians need to be mindful about the limitations of the current diagnostic approach for SMA in detecting non-deletion genotypes.https://www.frontiersin.org/articles/10.3389/fncel.2023.1259380/fullspinal muscular atrophy (SMA)c.796T>C variantg.27134T>G polymorphismAfrican Americannon-deletionmodeling
spellingShingle Leping Li
Lalith Perera
Sonia A. Varghese
Yael Shiloh-Malawsky
Senyene E. Hunter
Tam P. Sneddon
Cynthia M. Powell
A. Gregory Matera
Zheng Fan
A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
Frontiers in Cellular Neuroscience
spinal muscular atrophy (SMA)
c.796T>C variant
g.27134T>G polymorphism
African American
non-deletion
modeling
title A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
title_full A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
title_fullStr A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
title_full_unstemmed A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
title_short A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
title_sort homozygous missense variant in the yg box domain in an individual with severe spinal muscular atrophy a case report and variant characterization
topic spinal muscular atrophy (SMA)
c.796T>C variant
g.27134T>G polymorphism
African American
non-deletion
modeling
url https://www.frontiersin.org/articles/10.3389/fncel.2023.1259380/full
work_keys_str_mv AT lepingli ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT lalithperera ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT soniaavarghese ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT yaelshilohmalawsky ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT senyeneehunter ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT tampsneddon ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT cynthiampowell ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT agregorymatera ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT zhengfan ahomozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT lepingli homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT lalithperera homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT soniaavarghese homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT yaelshilohmalawsky homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT senyeneehunter homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT tampsneddon homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT cynthiampowell homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT agregorymatera homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization
AT zhengfan homozygousmissensevariantintheygboxdomaininanindividualwithseverespinalmuscularatrophyacasereportandvariantcharacterization